menu search

Could this biosimilar drug be novartis' next blockbuster?

novartis' biosimilar candidate to Eylea has proven just as safe and effective. The medicine could gener...

September 5, 2023, 10:15 am

novartis sues us government over medicare drug price regulation

Swiss drugmaker novartis on Friday said it had sued the U.S. government in an attempt to halt the Medic...

September 1, 2023, 4:20 pm

How much pain will lower medicare prices cause for pharma stocks?

Major pharmaceutical companies including Johnson & Johnson NYSE: JNJ, novartis AG NYSE: NVS, Bristol...

September 1, 2023, 7:01 am

novartis (nvs) announces positive long-term data on leqvio

novartis (NVS) Leqvio shows consistent efficacy and safety beyond six years in patients with ASCVD....

August 29, 2023, 10:31 am

Merck, amgen, abbvie products among first 10 drugs selected for medicare price negotiations

Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implica...

August 29, 2023, 7:50 am

novartis' (nvs) sandoz gets fda nod for tysabri's biosimilar

novartis' (NVS) generic division, Sandoz, wins FDA approval for a biosimilar of the leading MS drug Tys...

August 28, 2023, 12:02 pm

Oncology market's huge potential puts these stocks in focus

The oncology treatment market has been experiencing significant growth lately. Companies like Regeneron Pharmaceuticals (REGN), Merck & Co. (MRK), ...

August 28, 2023, 9:46 am

novartis’s sandoz gets fda approval for biosimilar multiple sclerosis drug

novartis’s Sandoz gets FDA approval for biosimilar multiple sclerosis drug Read Full Story The post <...

August 25, 2023, 5:55 am

Biogen stock slips after fda approves first biosimilar to tysabri ms treatment

Biogen Inc. BIIB, -0.90% shares slipped in the extended session Thursday after the Food and Drug Administration granted a soon-to-be ...

August 24, 2023, 6:07 pm

Cvs health launches biosimilars subsidiary, will commercialize humira competitor

CVS Health Corp. CVS, -0.97% said Wednesday that it has launched a new subsidiary that will work directly with drugmakers to co-produce and commercial...

August 23, 2023, 4:36 pm

5 large drug stocks to watch as new drug approvals & m&a gain pace

Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk ...

August 21, 2023, 11:16 am

novartis (nvs) plans to spin-off sandoz in early october

novartis (NVS) progresses with the proposed spin-off of its Sandoz arm (scheduled for early October) an...

August 18, 2023, 2:05 pm

novartis (nvs) key drugs and pipeline progress fuel growth

novartis (NVS) put up a strong performance year to date based on the solid performance of key drugs and...

August 15, 2023, 10:55 am

Bicycle therapeutics: decent upside opportunity, mid-stage data readouts due

Bicycle Therapeutics is an intriguing play in the drug development space. Using its fully synthetic short peptides, the company has developed two mid-...

July 31, 2023, 7:07 pm

Tg therapeutics: addressing the sc ocrevus concern

The launch of Briumvi is off to a solid start, but the stock pulled back recently and fell more after Roche reported positive phase 3 results of subcu...

July 29, 2023, 9:50 pm

2 stocks that raised their guidance in july

Many of novartis' top drugs saw their revenue generation grow by double digits this year. PepsiCo did n...

July 26, 2023, 10:01 am

novartis ag to spin-off sandoz business in 4q23

Deal Overview On July 18, 2023, novartis AG (NYSE: NVS, $105.01, Market Capitalization $239....

July 24, 2023, 11:13 am

Should income investors buy this blue chip stock?

novartis' exceptional lineup of medicines produced stellar results in Q2. The company's market-beating ...

July 23, 2023, 8:30 am

Diving into day one biopharmaceuticals

Shares of precision oncology concern Day One Biopharmaceuticals, Inc. are down over 50% from their 2023 high as ...

July 23, 2023, 4:43 am

Japan's daiichi sankyo gets us fda nod for blood cancer treatment

The U.S. Food and Drug Administration (FDA) approved Japan-based Daiichi Sankyo Co's treatment for newly diagnosed patients with an aggressive type of...

July 20, 2023, 5:26 pm


Search within

Pages Search Results: